Year: 2021
Type: review
Abstract: Cholesterol homeostasis is essential in normal physiology of all cells. One of several proteins involved in cholesterol homeostasis is the ATP-binding cassette transporter A1 (ABCA1), a transmembrane protein widely expressed in many tissues. One of its main functions is the efflux of intracellular free cholesterol and phospholipids across the plasma membrane to combine with apolipoproteins, mainly apolipoprotein A-I (Apo A-I), forming nascent high-density lipoprotein-cholesterol (HDL-C) particles, the first step of reverse cholesterol transport (RCT). In addition, ABCA1 regulates cholesterol and phospholipid content in the plasma membrane affecting lipid rafts, microparticle (MP) formation and cell signaling. Thus, it is not surprising that impaired ABCA1 function and altered cholesterol homeostasis may affect many different organs and is involved in the pathophysiology of a broad array of diseases. This review describes evidence obtained from animal models, human studies and genetic variation explaining how ABCA1 is involved in dyslipidemia, coronary heart disease (CHD), type 2 diabetes (T2D), thrombosis, neurological disorders, age-related macular degeneration (AMD), glaucoma, viral infections and in cancer progression.
DOI: 10.3390/ijms22041593
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Keywords: ABCA1, ABC transporters, cholesterol homeostasis, reverse cholesterol transport, HDL cholesterol, apolipoprotein A-I, lipid rafts, dyslipidemia, coronary artery disease, type 2 diabetes, thrombosis, neurological disorders, age-related macular degeneration, glaucoma, viral infection, tumor progression, genetic variation
Open Access status: gold
Estimated APC paid: $2,160
OpenAlex ID: W3126186575
